Events & Presentations

Kamada to Present at Stifel 2024 Healthcare Conference

Kamada to participate in the Stifel 2024 Healthcare Conference, scheduled for November 18-19, 2024, in New York, USA. This conference brings together healthcare leaders to discuss innovations and strategies in the field.

Kamada to Exhibit at the 2024 AABB Annual Meeting in Houston

Kamada to Exhibit at The 2024 American Academy of Pediatrics (AAP) National Conference

The American Academy of Pediatrics (AAP) continues to be a leader in developing world class innovative education sessions. 
Each year over 10,000 professionals attend, present and learn about the latest advances in Pediatric care at the National
Conference & Exhibition.

Kamada to exhibit at the annual American Transplantation Conference ( ATC )

Come meet us at our booth #1236 during the American Transplantation Conference (ATC) in San Diego, June 3-7th! We will be happy to chat and share updated information and insights about our hyper-immune therapy portfolio, focusing on CMV and Varizella Zoster prevention in transplanted patients.    

KAMADA to participate and exhibit at the International Society for Heart and Lung Transplantation (ISHLT)

The 2023 scientific program features three General (Plenary) Sessions and more than 120 symposia and abstract sessions scheduled throughout the meeting. Full details for sessions of all types, including session descriptions, talk titles, and faculty can be found on the Program Viewer, which can be filtered by core therapy and professional specialty.

Kamada to participate at the Alpha-1 National Conference

The Alpha-1 National Conference is the largest annual gathering of Alphas, their families, leading healthcare professionals, and industry in the world. It is a three-day event with educational programs given by national experts and leaders in the Alpha-1 field. The conference provides a unique opportunity to increase your understanding of Alpha-1 and network with patients diagnosed with Alpha-1, their families, industry, and healthcare professionals such as respiratory therapists, nurse practitioners, physicians, and nurses.

Kamada to Host a Virtual Analysts and Investors Meeting to Review its Growth Catalysts

Kamada will host a virtual analysts and investors meeting  on Tuesday, June 7, 2022, at 12:00 PM Eastern Time to review its growth catalysts. To register for the meeting please click here. The meeting will feature a presentation by Amir London, Chief Executive Officer, Chaime Orlev, Chief Financial Officer, and Jon R. Knight, Vice President, U.S. Commercial Operations, who will discuss Kamada’s strategic evolution into a fully-integrated specialty plasma company with six FDA-approved products and strong commercial capabilities in the U.S. market, as well as a global commercial footprint in over 30 countries. A live questions and answers session will follow the formal presentation. To register for the meeting, please click here.  

Kamada to Announce First Quarter Ended March 31, 2022 Financial Results and Host Conference Call on May 17, 2022

Kamada management will host an investment community conference call on Tuesday, May 17, at 8:30am Eastern Time to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 1-877-407-0792 (from within the U.S.), 1 809-406-247 (from Israel), or 1-201-689-8263 (International) and entering the conference identification number: 13729770.  The call will also be webcast live on the Internet at: https://viavid.webcasts.com/starthere.jsp?ei=1547283&tp_key=3051633ddd

Kamada management will host an investment community conference call

Kamada management will host an investment community conference call on Tuesday, March 15, at 8:30am Eastern Time to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 877-407-0792 (from within the U.S.), 1 809-406-247 (from Israel), or 201-689-8263 (International) and entering the conference identification number: 13727620.  The call will also be webcast live on the Internet at: https://viavid.webcasts.com/starthere.jsp?ei=1533883&tp_key=876a5d54ec The call will also be archived for 90 days on the Company’s website at www.kamada.com.

Kamada to Host Third Quarter 2021 Earnings Conference Call

Kamada management will host an investment community conference call on Monday, November 22, at 8:30am Eastern Time to discuss the strategic acquisition and these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 877-407-0792 (from within the U.S.), 1-809-406-247 (from Israel), or 201-689-8263 (International) and entering the conference identification number: 13724183.